Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Cancer Diagnosis & Prognosis|April 11, 2022
FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study)Yukimasa Hatachi, Sharad R Mohan, Takeshi Kotake, et al.
International Journal of Clinical Oncology|January 16, 2020
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanomaMotoo Nomura, Isao Oze, Toshiki Masuishi, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2018
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxaneHironaga Satake, Tamotsu Sagawa, Koshi Fujikawa, et al.
Frontiers in Oncology|August 27, 2025
A placebo-controlled study of the doses and efficacy of Lentinula edodes mycelia for oxaliplatin-induced peripheral neuropathy in colorectal cancerShogen Boku, Hironaga Satake, Seiichiro Mitani, et al.
Journal of Clinical Medicine|October 27, 2022
Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab TherapyTatsuki Ikoma, Toshihiko Matsumoto, Yusuke Kurioka, et al.
Molecular and Clinical Oncology|September 13, 2017
First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I studyHironaga Satake, Hisateru Yasui, Takeshi Kotake, et al.
BMC Cancer|November 18, 2020
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancerHironaga Satake, Koji Ando, Eiji Oki, et al.
Clinical Journal of Gastroenterology|January 10, 2022
Curative resection of ureteral metastasis of rectal cancer: a case report and review of literatureYuki Matsui, Madoka Hamada, Yuki Matsumi, et al.
Plos One|June 13, 2020
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in JapanMisato Ogata, Masahito Kotaka, Takatsugu Ogata, et al.
BMC Cancer|May 8, 2021
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in JapanTatsuki Ikoma, Mototsugu Shimokawa, Masahito Kotaka, et al.
Pageof 12